Carolyn Glass
Assistant Professor of Pathology

Current Research Interests

Cardiac and Thoracic Pathologist
Chief, Cardiovascular Pathology 
Co-Director, Division of Artificial Intelligence and Computational Pathology
Associate Director of Immuno-Oncology, Duke Biorepository and Precision Pathology Center (BRPC)
Director, Duke University Hospital Autopsy Service 

Dr. Glass initially trained as a vascular surgeon with a focus on endovascular/interventional procedures through the Integrated Vascular Surgery Program at the University of Rochester Medical Center. After receiving her PhD in the areas of genomics and epigenetics, she subsequently completed residency in Anatomic Pathology and a Cardiothoracic Pathology fellowship at the Brigham and Women’s Hospital/Dana Farber Cancer Institute/Harvard Medical School and an additional fellowship in Thoracic Pathology at the University of Texas Southwestern Medical Center. Dr. Glass was mentored by Drs. Gayle Winters, Richard Mitchell and Fred Schoen, distinguished cardiovascular pathologists at BWH/Harvard instrumental in defining the International Society Heart and Lung Transplant Criteria for cardiac transplant rejection and numerous other seminal contributions to the field of cardiac pathology. 

Dr. Glass is the recipient of the Society of Cardiovascular Pathology (SCVP) Young Investigator’s Award, the William von Liebig Vascular Biology Research Fellowship at the Harvard Institutes of Medicine, the Duke Pathology Salvatore V. Pizzo Faculty Research Mentor Award, and is author of numerous publications and national presentations in cardiovascular disease, thoracic malignancies and surgery. She has active collaborations with the Duke Departments of Cardiology, Cardiothoracic Surgery, Electrical Engineering/Computer Science and Oncology investigating areas such as artificial intelligence, immune checkpoint/targeted cancer therapy toxicity, novel molecular biomarkers and transplant rejection.

As a thoracic pathologist, Dr. Glass also diagnoses lung/mediastinal/pleural malignancies and non-neoplastic lung diseases. She has a special interest in identifying new epigenetic biomarkers that may predict response or resistance to conventional, targeted and immune therapy using computational techniques. She works closely with the Duke Thoracic Oncology Group and DCI Center for Cancer Immunotherapy and is author of several cardiac and thoracic topics in the 5th edition of the W.H.O. Classification Tumours of the Lung, Pleura, Thymus and Heart.     

Current Appointments & Affiliations

Contact Information

  • 214D Davison Building, 40 Duke Medicine Circle, Box #3712 Duhs, Durham, NC 27710

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.